|
NPPA seeks market-based price data on four IVs for ceiling price fixation
|
|
Gireesh Babu, New Delhi
January 25 , 2025
|
|
|
The National Pharmaceutical Pricing Authority (NPPA) has asked the manufacturers and marketers to submit price data on four intravenous (IV) fluids at certain strengths, in order to fix the ceiling prices as per the revised Schedule I of the Drugs Prices Control Order (DPCO), 2013.
The Authority, in a communication on January 21, sought the industry players to submit the Price to Retailer (PTR) and Moving Annual Turnover (MAT) values for the formulations for the month of October, 2023.
The formulations for which the details has been sought for include glucose injection 5%, 10% and 50%strengths, a combination of glucose 5% and sodium chloride 0.9% injection, sodium chloride injection 0.9% and 3%, and finally, Ringer lactate injection (strength as per IP).
The information may be furnished in a format provided by the NPPA, showing the pack size, type of packaging etc., along with the Form II and Form V as well as licenses. The information should be furnished positively within 10 days from the date of issue of the order, it added.
The information has been sought by the Authority in order to take appropriate action based on the available data, on fixation of the ceiling prices of these IV fluids under the revised Schedule I of the DPCO, 2013. The Schedule I was revised in 2023, replacing the list of medicines based on the National List of Essential Medicines (NLEM), 2015, with the NLEM, 2022, in the schedule.
The Department of Pharmaceuticals has notified the revision of the Schedule I with the NLEM, 2022 on November 11, 2022, and the NPPA started the procedures to fix or revise the ceiling prices of a total of 954 formulations, comprising 388 medicines, following this.
While the general practice is that the ceiling prices are fixed considering the market-based data available for the month ending immediately before six months of the notification of the revision of the Schedule I. However, the Authority decided to use the data from July, 2022, paying heed to the representations from the industry associations that the data of April, 2022 would not reflect the existing Price to Retailer (PTR) or Maximum Retail Price (MRP), considering the ceiling price revision carried out in the beginning of April, 2022 based on the WPI issued in March, 2022.
The Authority later revised this policy to adopt the pricing data for the month of October, 2023, in order to keep the pricing updated.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|